A deodorant stick comprising at least 25% by weight liquid triglyceride; a primary antimicrobial having a water solubility of at most about 90 g/L at 25° C.; a fragrance composition comprising at least about 50% natural oils, essential oils, or a combination thereof; and a primary structurant with a melting point of at least 50° C.; said deodorant stick being free of an aluminum salt; and said deodorant stick having a hardness from about 70 mm*10 to about 140 mm*10, as measured by penetration with ASTM D-1321 needle.

A personal cleansing composition comprising a piroctone compound and a cleansing surfactant comprising an amphoteric surfactant and an ethoxylated anionic surfactant in which the anionic surfactant has an average degree of ethoxylation of 2.5 or greater.

Heterocyclic compounds are provided. In particular, the heteroatom of the heterocyclic compound may be nitrogen. The heterocyclic compounds may demonstrate capacity of stabilizing photoactive compounds. Topical compositions comprising these heterocyclic compounds are also provided. In particular, these topical compositions further comprise photoactive compounds. Methods for stabilizing photoactive compounds are also provided. These methods comprise mixing the photoactive compounds with photostabilizing heterocyclic compounds.

A discrete dispensed product comprising a first portion; and a second portion at least partially surrounding the first portion provides a premium and distinct appearance to consumers.

An oral care composition for alleviating dentin hyperesthesia is disclosed. The oral care composition includes a peptide consisting of an amino acid sequence of the following Formula 1:
K—Y-R1-R2-R3-R4-R5-R6-R7-R8  (Formula 1) wherein R1 is arginine (R), lysine (K) or glutamine (Q); R2 is arginine (R) or glutamine (Q); R3, R4, and R5 are arginine (R) or lysine (K), respectively; R6 is asparagine (N) or serine(S); and R7 and R8 are lysine (K) or tyrosine (Y), respectively.

Water-in-oil sunscreen emulsion compositions including an aqueous phase emulsified within an external fatty phase are provided. The external fatty phase includes at least one silicone fatty compound and at least about 10% by weight of organic UV filters with respect to the entire sunscreen composition. The compositions include an emulsifying silicone elastomer and a non-elastomeric silicone surfactant.

The compositions further include swellable clay and pigment.

The present invention relates to a compound represented by the following formula (I): A[B—(C).sub.v].sub.w, wherein A is a photoprotective moiety, B is a linker, C is a functional group, v is an integer from 1 to 2000, and w is an integer from 1 to 6. It also relates to a composition comprising the same and, more particularly, to a cosmetic or a sunscreen composition. It also relates to the use of such compounds in cosmetic and therapeutic applications. The invention also relates to the use of such compounds for reducing photodegradation and/or photoinstability of pharmaceuticals and cosmetics. The invention further relates to a material comprising a support and such a compound adhered to said support.

The present invention provides three embodiments to create and apply a tattoo to a dermal area of a recipient wherein the tattoo is non-permanent. The present invention includes a first embodiment and a second embodiment wherein the tattoo ink is removable via introduction of a solution and/or a solvent. A third embodiment of the present invention provides a method for tattoo ink creation that provides a tattoo ink that will degrade within the aqueous bodily environment over a period of time based on the polymer with which the water soluble dye is created. The first embodiment utilizes an organic dye that contains at least one metal atom. A solution containing a chelating agent is presented to the tattooed area wherein the chelating agent will extract the metal atom resulting in disappearance of the tattoo ink. Another embodiment utilizes wax encapsulated ink to be removed by presentation of a solvent.

A method of assessing the impact of a test perfume composition on the well-being of human subjects is provided, as well as a method of preparing or optimizing a perfume composition for enhancing the well-being of a human subject, perfume compositions that enhance the well-being, and consumer products containing them.

A core shell microcapsule having a liquid core and an outer shell, in which the liquid core comprises solvent and a piroctone compound and the shell comprises polyurea comprising amino sulphonic acid.